Stimulation of non-α7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture

Neuroscience

Volumn 109, Issue 2, 2002, Pages 275-285

  Jeyarasasingam, G ^a   Tompkins, L ^a   Quik, M ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

1 methyl 4 phenylpyridinium; Mesencephalic cells; Neuroprotection; Nicotine; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA BUNGAROTOXIN; EPIBATIDINE; LIGAND; NEUROTOXIN; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; TUBOCURARINE CHLORIDE; ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; DOPAMINE; NEUROPROTECTIVE AGENT; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; LIGAND BINDING; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; ANIMAL; CELL DEATH; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; ORGAN CULTURE TECHNIQUE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; TOBACCO DEPENDENCE;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL DEATH; DOPAMINE; FEMALE; IMMUNOHISTOCHEMISTRY; NEURONS; NEUROPROTECTIVE AGENTS; NICOTINE; ORGAN CULTURE TECHNIQUES; PARKINSON DISEASE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA; TOBACCO USE DISORDER; TYROSINE 3-MONOOXYGENASE;

EID: 0037185083     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00488-2     Document Type: Article

References (76)

1. Ultrastructural localization of the α4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra
2. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within rat midbrain dopaminergic neurons
3. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders
4. Cigarette smoking and Parkinson's disease
5. Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious
6. Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
7. The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain
8. The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions
9. Evidence that tobacco smoking increases the density of 3H-nicotine binding sites in human brain
10. 3H-nicotine binding in human postmortem brain
11. Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors
12. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke
13. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture
14. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture
15. A role for the nicotinic α-bungarotoxin receptor in neurite outgrowth in PC12 cells
16. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area
17. Autoradiographic evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurons
18. 125I]-α-bungarotoxin
19. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion
20. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra
21. Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
22. Nicotinic receptor binding sites in rat primary neuronal cells in culture: Characterization and their regulation by chronic nicotine
23. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
24. 6-Hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression
25. Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo
26. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection
27. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area
28. 2+ and cAMP in nicotine-elicited elevation of tyrosine hydroxylase mRNA
29. Involvement of alpha7 nicotinic acetylcholine receptors in activation of tyrosine hydroxylase and dopamine beta-hydroxylase gene expression in PC12 cells
30. Nicotine exposure and Parkinson disease
31. Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists
32. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat
33. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
34. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse
35. Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: A microdialysis study
36. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse
37. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyrridine by dopamine neurons explains selective toxicity
38. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors
39. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity
40. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei
41. Characterization of nicotinic receptors in immortalized hippocampal neurons
42. Parkinson's disease. First of two parts
43. Parkinson's disease. Second of two parts
44. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain
45. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion
46. alpha7 nicotinic receptor mediated protection against ethanol-induced cytotoxicity in PC12 cells
47. Characterization of the neuroprotective and toxic effects of α7 nicotinic receptor activation in PC12 cells
48. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism
49. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors
50. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate
51. Effects of chronic nicotine infusion on tolerance development and cholinergic receptors
52. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
53. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain
54. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties
55. Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons
56. Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
57. 3H]Cytisine binding to nicotinic cholinergic receptors in brain
58. Increased nAChRs in brains from smokers: Membrane binding and autoradiography studies
59. Alteration in nicotinic receptor subunit mRNAs in monkey brain after nigrostriatal degeneration
60. Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization
61. 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey
62. Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocyte progenitor cells
63. Nicotinic cholinergic receptor binding sites in the brain: Regulation in vivo
64. 3H]acetylcholine in rat brain
65. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: Partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone pretreatment
66. From the Cover: Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores
67. Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain
68. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat
69. Adrenal tyrosine hydroxylase activity and gene expression are increased by intraventricular administration of nicotine
70. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties
71. Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta
72. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat
73. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells
74. Presynaptic nicotinic Ach receptors
75. Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: Correlation between receptor changes and behavioural function
76. Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism